1006901-06-9Relevant academic research and scientific papers
THERAPEUTIC AGENT FOR URINARY TRACT DISEASE
-
, (2009/12/07)
Disclosed is a treating agent of overactive bladder syndrome, pollakiuria, urinary incontinence, dysuria in benign prostatic hyperplasia or urolithiasis, which comprises a compound having PDE9-inhibiting activity as the active ingredient.
QUINAZOLINE DERIVATIVE
-
Page/Page column 12, (2009/05/29)
The invention discloses quinazoline derivatives or salts thereof, which possess PDE9-inhibiting activity and are useful as treating agents of dysuria and the like, the derivatives being represented by the formula (I) in the formula, R1 stands f
